Development and in vitro validation of anti-mesothelin biobodies that prevent CA125/mesothelin-dependent cell attachment

被引：59

作者：

Bergan, Lindsay ^{[1
]}

Gross, Jennifer A. ^{[1
]}

Nevin, Barry ^{[1
]}

Urban, Nicole ^{[1
]}

Scholler, Nathalie ^{[1
]}

机构：

[1] Fred Hutchinson Canc Res Ctr, Mol Diagnost Progarm, Seattle, WA 98109 USA

来源：

CANCER LETTERS | 2007年 / 255卷 / 02期

关键词：

mesothelin; CA125; biobody; tumor cell attachment; ovarian cancer; peritoneal metastasis;

D O I：

10.1016/j.canlet.2007.04.012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Preventing peritoneal implantation of carcinoma cells could prolong ovarian cancer patient remission and survival. Peritoneal cells constitutively express mesothelin, a ligand for CA 125 that is expressed by tumor cells. Thus blocking CA 125/ mesothelin-dependent cell attachment may prevent or delay peritoneal metastatic recurrence. We developed a high-throughput screening system for reagents able to block CA125/mesothelin-dependent cell attachment with a sensitive quantitative readout. Using a novel yeast-expression system to produce secreted, in vivo biotinylated proteins and biobodies (Bbs), we generated anti-mesothelin Bbs. Anti-mesothelin Bbs derived from high affinity yeast-display scFv detected both membrane-bound and soluble mesothelins and inhibited CA125/mesothelin-dependent cell attachment. Published by Elsevier Ireland Ltd.

引用

页码：263 / 274

页数：12

共 42 条

[21]

HO M, 2006, BIOMARKERS PREV, V15, P1751

[22] A 10-MINUTE DNA PREPARATION FROM YEAST EFFICIENTLY RELEASES AUTONOMOUS PLASMIDS FOR TRANSFORMATION OF ESCHERICHIA-COLI [J].

HOFFMAN, CS ;

WINSTON, F .

GENE, 1987, 57 (2-3) :267-272

[23] Immunogenicity of engineered antibodies [J].

Hwang, WYK ;

Foote, J .

METHODS, 2005, 36 (01) :3-10

[24]

Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614

[25] Progress and challenges in screening for early detection of ovarian cancer [J].

Jacobs, IJ ;

Menon, U .

MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (04) :355-366

[26] CA-125 IN GYNECOLOGICAL PATHOLOGY - A REVIEW [J].

KENEMANS, P ;

YEDEMA, CA ;

BON, GG ;

VONMENSDORFFPOUILLY, S .

EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1993, 49 (1-2) :115-124

[27] HUMAN IMMUNE-RESPONSE TO MONOCLONAL-ANTIBODIES [J].

KHAZAELI, MB ;

CONRY, RM ;

LOBUGLIO, AF .

JOURNAL OF IMMUNOTHERAPY, 1994, 15 (01) :42-52

[28] Expression of CA-125 by progestational bovine endometrium: prospective regulation and function [J].

McDonnel, AC ;

Van Kirk, EA ;

Austin, KJ ;

Hansen, TR ;

Belden, EL ;

Murdoch, WJ .

REPRODUCTION, 2003, 126 (05) :615-620

[29] OCCURRENCE OF THE MUCINOUS DIFFERENTIATION ANTIGEN CA125 IN GENITAL-TRACT AND CONDUCTIVE AIRWAY EPITHELIA OF DIVERSE MAMMALIAN-SPECIES (RABBIT, DOG, MONKEY) [J].

NOUWEN, EJ ;

DAUWE, S ;

DEBROE, ME .

DIFFERENTIATION, 1990, 45 (03) :192-198

[30] More than 15 years of CA 125: What is known about the antigen, its structure and its function [J].

O'Brien, TJ ;

Tanimoto, H ;

Konishi, I ;

Gee, M .

INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1998, 13 (04) :188-195

← 1 2 3 4 5 →